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Introduction
Mutations M680I, M694V and V726A of Pyrin - the pro-
duct of MEFV gene - are localized at the domain B30.2
(PB30.2D) and responsible for manifestation of the most
widespread and severe forms of FMF. From the other
hand, it is well known that malfunction of the pyrin-cas-
pase-1complex is the main reason for inflammation during
FMF. Therefore, we suggest that comparative investigation
of normal and mutated pyrin and caspase-1 interaction
will help to reveal possible link between those mutations
and structural changes that influence formation of pyrin-
caspase-1 complex.
Objectives
From abovementioned the goal of current study was to
detect possible changes in the tertiary structure of B30.2
and to show structural consequences that influence forma-
tion of pyrin-caspase-1 complex.
Methods
3D structures of M680I, M694V and V726A was build up
with the help of Rosetta software, caspase-1and B30.2
files obtained from PDB. Alignment of native B30.2 with
three mutant forms has been done by VMD programme.
In silico molecular modeling interaction experiments
between native and mutated B30.2 and caspase-1 has
been performed by CHARMM software in in Effective
Energy Function 1 environment using 24-node computer
cluster. Each molecular modeling time was 110ns with
iteration 2fs.
Results
Influence of mutations on B30.2 tertiary structure has
revealed the following structural changes: M680I –
induces conversion of b-sheet into loop in position
THR663-TRP665, loop - b-sheet in THR707- LEU710 and
loop - a-helix in LYS765 – ALA768 site. Alignment of
the native structure with mutation has RMSD=1,137 Å.
M694V – conversion of the loop into b-sheet in the sites
LYS695-GLU696 and THR707 – LEU709, RMSD=1,699
Å. V726A – conversion b-sheet into loop in the sites
TRP655 – VAL657, loop - b-sheet in THR707- LEU710
and ARG725 – GLY727, loop - a-helix in ASP762 –
LYS765, RMSD=1,808 Å. Molecular modeling of B30.2-
caspase-1 dynamic interaction has shown significant
differences between interaction energy of normal and
mutated domains. Decrease in the minimal and average
complex formation energy in the case of V726A (71 and
69% in comparison to the normal domain), no changes for
M680I (99 and 97.4%) and increase for M694V (136.5 and
126,5%). At the same time maximal energy values have
not shown any considerable differences.
Conclusion
Summarizing results of impact of the mutations on the
B30.2-caspase-1 complex formation we came to the con-
clusion that dramatic changes in the tertiary structures
which reflected in the shifts of binding sites and differ-
ences of interaction energy have notable influence on
the complex formation, which in its turn should affect
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